$0
$28,000
0.0% of portfolio
281,888
Q4 2023
Reduced 13.18%
$38.6M
$47,000
0.0% of portfolio
61,840
Q4 2023
Reduced 26.79%
-
$0
0.0% of portfolio
-
Q3 2024
Added 11.02%
$2.07B
$267,000
0.0% of portfolio
10,782
Q4 2022
New
$9.91B
$251,000
0.0% of portfolio
6,307
Q3 2024
Added 6.47%
$45.9B
$291,000
0.0% of portfolio
93,854
Q3 2024
Added 9.52%
$6.03B
$222,000
0.0% of portfolio
31,302
Q3 2024
New
$2.32B
$123,000
0.0% of portfolio
12,264
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 106.81%
$23.7B
$330,000
0.0% of portfolio
211
Q3 2024
New
$3.6B
$201,000
0.0% of portfolio
2,737
Q3 2024
New
$6.4B
$255,000
0.0% of portfolio
5,162
Q3 2024
New
$2.26B
$351,000
0.0% of portfolio
60,005
Q3 2024
Reduced 0.25%
$5.71B
$251,000
0.0% of portfolio
1,224
Q3 2024
New
$142B
$198,000
0.0% of portfolio
19,491
Q3 2024
Added 12.44%
-
$0
0.0% of portfolio
-
Q3 2024
Added 100.0%
$186M
$15,000
0.0% of portfolio
42,214
Q3 2021
New
$4.59B
$207,000
0.0% of portfolio
2,800
Q3 2024
New
$11.6B
$259,000
0.0% of portfolio
528
Q3 2024
Added 2.52%
$5.59B
$329,000
0.0% of portfolio
5,435
Q3 2024
Added 0.83%
$43.1B
$209,000
0.0% of portfolio
3,007
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 23.61%
$171M
$28,000
0.0% of portfolio
21,978
Q2 2024
Reduced 8.97%
-
$0
0.0% of portfolio
-
Q3 2024
New
$816M
$339,000
0.0% of portfolio
16,937
Q1 2024
New
$0
$142,000
0.0% of portfolio
11,089
Q3 2024
Added 0.82%
Neumora Therapeutics Inc.
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 9.66%
$3.01B
$135,000
0.0% of portfolio
14,940
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
$4.21B
$278,000
0.0% of portfolio
36,308
Q3 2024
New
$6.2B
$291,000
0.0% of portfolio
1,766
Q3 2024
New
$24.1M
$51,000
0.0% of portfolio
37,342
Q2 2023
New
$370M
$104,000
0.0% of portfolio
41,968
Q4 2023
Reduced 0.24%
$17.4B
$99,000
0.0% of portfolio
19,089
Q3 2024
Reduced 10.79%
$12.1B
$375,000
0.0% of portfolio
1,429
Q3 2024
Reduced 30.73%
$11.1B
$254,000
0.0% of portfolio
12,427
Q3 2024
Reduced 39.4%
$0
$193,000
0.0% of portfolio
14,461
Q3 2024
Added 0.01%
$0
$239,000
0.0% of portfolio
20,000
Q2 2024
Reduced 19.08%
$0
$200,000
0.0% of portfolio
16,839
Q3 2024
Added 1.49%
$0
$136,000
0.0% of portfolio
15,000
Q2 2024
Reduced 6.25%
$0
$92,000
0.0% of portfolio
10,480
Q2 2024
Reduced 1.23%
$0
$201,000
0.0% of portfolio
25,003
Q2 2024
Reduced 5.84%
$641M
$153,000
0.0% of portfolio
17,629
Q2 2024
Reduced 41.49%
$8.94B
$358,000
0.0% of portfolio
8,811
Q3 2024
New
$8.58B
$398,000
0.0% of portfolio
1,920
Q3 2024
New
$3.75B
$238,000
0.0% of portfolio
12,490
Q3 2024
Reduced 1.19%
$9.86B
$325,000
0.0% of portfolio
8,499
Q3 2024
Added 75.89%
$438M
$19,000
0.0% of portfolio
11,424
Q2 2024
Reduced 0.41%
$1.07B
$50,000
0.0% of portfolio
10,213
Q3 2024
New
$3.39B
$272,000
0.0% of portfolio
19,314
Q3 2024
New